REPROCELL and BioBridge Global sign Memorandum of Understanding to accelerate global manufacturing services using clinical iPSCs

Validation of a Commercial Immunoassay for Detecting Hepatitis B Surface Antibody in Human Immune Globulin Products

Validation of Commercial Immunoassays for Detecting HBsAg and HIV Antibodies in Production Pools

Implementation of a Sample Catalogue Storage System

Implementation of Automation in a High-Throughput Production Laboratory

Comparison of Qualitative Versus Quantitative PCR Safety Assays

Unique Community-Centered Collaboration to Create COVID-19 Safety Zones

Development of An Automated Reactive Rate Metrics Dashboard

Qualifying Blood Screening NAT Assays for Safety Testing of Cellular Based Therapeutics

Sars-CoV2 Antibody Testing: A Comparison of Two Assay Platforms to Designate Convalescent Plasma as High Titer

Sensitivity and specificity of a new automated system for the detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus nucleic acid in blood and plasma donations

Frequent detection of the parvoviruses, PARV4 and PARV5, in plasma from blood donors and symptomatic individuals

First report of human immunodeficiency virus transmission via an RNA-screened blood donation